Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo

Table 2

Distribution of demographic and clinical parameters across diseases severity groups.

		Mild	Moderate	Severe	Critical	value
		9	23	50	4
Sex	Male	3	12	32	3	0.286^a
Age	Mean ranks	15.50	38.17	49.62	60.63	0.001^b
Comorbidities
Hypertension	Yes	1	10	24	2	0.228^a
Diabetes	Yes	0	1	13	1	0.062^a
Cancer	Yes	0	4	2	1	0.107^a
Hospitalisation	Yes	1	18	50	4	≤0.001^a
Medications used during illness
Corticosteroids	Yes	0	21	46	4	≤0.001^a
Antivirals	Yes	2	13	27	3	0.230^a
Antibiotics	Yes	7	23	50	2	≤0.001^a

values less than 0.05 are highlighted in italic. ^aPearson χ2 test. ^bKruskal–Wallis test.